AERI
Aerie Pharmaceuticals, Inc.
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
161 hedge funds and large institutions have $1.23B invested in Aerie Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
+57
Holders Change %
+54.81%
% of All Funds
4.3%
Holding in Top 10
8
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+300%
% of All Funds
0.21%
New
61
Increased
49
Reduced
35
Closed
4
Calls
$34.6M
Puts
$26.8M
Net Calls
+$7.76M
Net Calls Change
+$3.48M
Top Buyers
| 1 |
O
OrbiMed
New York
|
$30.1M |
| 2 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
$63.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$21.1M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
$18.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
$22.5M |
